2 posts tagged by Digg
Science
A post citing CNN says the Cleveland Clinic trial enrolled 15 people with lipid disorders resistant to medication. The treatment, CTX310, edits the ANGPTL3 gene in liver cells.
Science
A cardiologist reports about a 53% LDL cholesterol reduction at the highest dose in a 15-patient Phase 1a trial of CTX310. The account stresses that larger, longer studies are needed and the therapy is not FDA-approved.
